We analyzed the expression of 42 genes associated with these pathways in 40 OSNA ++ SLNs of luminal B (HER2-negative) BC patients, which included 20 relapsing subjects and 20 tumor recurrence-free patients (Supplementary Table 1). This evidence concerns the gene ERBB2 and breast cancer.